Wikstrand John
Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden.
Clin Physiol Funct Imaging. 2007 Nov;27(6):341-5. doi: 10.1111/j.1475-097X.2007.00757.x.
With an increasing number of randomized studies investigating the anti-atherosclerotic effects of different preventive measures utilizing ultrasound evaluation of intima-media thickness of the carotid artery as the primary endpoint, it is of interest to critically evaluate the validity of these measurements.
Small structures, the dimensions of which are far beyond the resolution limits of the equipment, may produce an ultrasound echo. Thus the very thin interface between two fluids such as oil and water will produce an echo that is much thicker than the interface itself, which is infinitely thin. Thus, the thickness of any echo defining an interface is of no anatomical interest. The thickness of an anatomical entity, such as the intima-media complex, is always defined as the distance between the leading edges of two different echoes. In spite of the similarity of the near and far wall images the thickness of the intima-media complex can only be measured in a valid way in the far wall position.
We conclude that main outcome variables in ultrasound studies of atherosclerosis should be from the far wall. It would seem advisable to focus on far wall common carotid artery and carotid artery bulb recordings. It is likely that including near wall measurements and measurements from the internal carotid artery will decrease measurement precision and lead to increases in sample size in scientific studies; or even dilute positive results in an otherwise well designed study.
随着越来越多的随机研究利用颈动脉内膜中层厚度的超声评估作为主要终点来探究不同预防措施的抗动脉粥样硬化作用,严格评估这些测量的有效性变得很有意义。
尺寸远远超出设备分辨率极限的小结构可能产生超声回声。因此,两种流体(如油和水)之间非常薄的界面会产生一个比界面本身厚得多的回声,而界面本身是无限薄的。因此,定义界面的任何回声的厚度都没有解剖学意义。解剖实体(如内膜中层复合体)的厚度总是定义为两个不同回声前沿之间的距离。尽管近壁和远壁图像相似,但内膜中层复合体的厚度只能在远壁位置以有效的方式测量。
我们得出结论,动脉粥样硬化超声研究中的主要结果变量应来自远壁。似乎最好专注于远壁颈总动脉和颈动脉球部的记录。在科学研究中纳入近壁测量和颈内动脉测量可能会降低测量精度并导致样本量增加;甚至可能在原本设计良好的研究中稀释阳性结果。